Published in Immunol Cell Biol on February 01, 1998
Identification of genetic loci controlling the characteristics and severity of brain and spinal cord lesions in experimental allergic encephalomyelitis. Am J Pathol (2000) 1.32
Connexin43, the major gap junction protein of astrocytes, is down-regulated in inflamed white matter in an animal model of multiple sclerosis. J Neurosci Res (2005) 1.14
Molecular grafting onto a stable framework yields novel cyclic peptides for the treatment of multiple sclerosis. ACS Chem Biol (2013) 0.97
P-glycoprotein acts as an immunomodulator during neuroinflammation. PLoS One (2009) 0.90
Effects of acute and repeated exposure to lipopolysaccharide on cytokine and corticosterone production during remyelination. Brain Behav Immun (2007) 0.80
Oral Administration of Lactococcus lactis Expressing Synthetic Genes of Myelin Antigens in Decreasing Experimental Autoimmune Encephalomyelitis in Rats. Med Sci Monit (2015) 0.80
Increased spontaneous ex vivo apoptosis and subset alterations in peripheral blood T cells from patients with multiple sclerosis. J Clin Immunol (2006) 0.79
Immunosuppressive potential of human amnion epithelial cells in the treatment of experimental autoimmune encephalomyelitis. J Neuroinflammation (2015) 0.78
An investigation of polymorphisms in the 17q11.2-12 CC chemokine gene cluster for association with multiple sclerosis in Australians. BMC Med Genet (2006) 0.78
Depression and multiple sclerosis: a potential way to understand the biology of major depressive illness. J Psychiatry Neurosci (2005) 0.77
Mesenchymal stem cells are mobilized from the bone marrow during inflammation. Front Immunol (2013) 0.77
IFN-gamma plays a critical down-regulatory role in the induction and effector phase of myelin oligodendrocyte glycoprotein-induced autoimmune encephalomyelitis. J Immunol (1996) 5.38
The influence of the proinflammatory cytokine, osteopontin, on autoimmune demyelinating disease. Science (2001) 4.89
Limited heterogeneity of rearranged T-cell receptor V alpha transcripts in brains of multiple sclerosis patients. Nature (1990) 3.30
Granulocyte macrophage colony-stimulating factor: a new putative therapeutic target in multiple sclerosis. J Exp Med (2001) 2.60
TNF is a potent anti-inflammatory cytokine in autoimmune-mediated demyelination. Nat Med (1998) 2.42
B cell repertoire diversity and clonal expansion in multiple sclerosis brain lesions. J Immunol (1999) 2.06
Selection for T-cell receptor V beta-D beta-J beta gene rearrangements with specificity for a myelin basic protein peptide in brain lesions of multiple sclerosis. Nature (1993) 2.01
IL-6-deficient mice are resistant to the induction of experimental autoimmune encephalomyelitis provoked by myelin oligodendrocyte glycoprotein. Int Immunol (1998) 2.00
Reactivity to myelin antigens in multiple sclerosis. Peripheral blood lymphocytes respond predominantly to myelin oligodendrocyte glycoprotein. J Clin Invest (1993) 1.62
T-cell receptor V alpha and C alpha alleles associated with multiple and myasthenia gravis. Proc Natl Acad Sci U S A (1989) 1.47
Experimental autoimmune encephalomyelitis in mice: genetic control of susceptibility. J Immunogenet (1976) 1.27
Elicitation of experimental allergic encephalomyelitis (EAE) in mice with the aid of pertussigen. Cell Immunol (1984) 1.20
Induction of a multiple sclerosis-like disease in mice with an immunodominant epitope of myelin oligodendrocyte glycoprotein. Autoimmunity (1998) 1.20
The structure and function of myelin oligodendrocyte glycoprotein. J Neurochem (1999) 1.20
Suppressor T cells prevent experimental autoimmune encephalomyelitis in mice. Clin Exp Immunol (1977) 1.19
Immunopathology of murine experimental allergic orchitis. J Immunol (1983) 1.15
T-cell reactivity to multiple myelin antigens in multiple sclerosis patients and healthy controls. J Neurosci Res (2001) 1.14
T cell necessity in the pathogenesis of experimental autoimmune encephalomyelitis in mice. Eur J Immunol (1976) 1.14
Experimental autoimmune encephalomyelitis in mice: immunologic response to mouse spinal cord and myelin basic proteins. J Immunol (1975) 1.12
Myelin oligodendrocyte glycoprotein induces a demyelinating encephalomyelitis resembling multiple sclerosis. J Immunol (1995) 1.10
Targeted expression of baculovirus p35 caspase inhibitor in oligodendrocytes protects mice against autoimmune-mediated demyelination. EMBO J (2000) 1.08
Identification of two human brain aryl sulfotransferase cDNAs. Biochem Biophys Res Commun (1993) 1.01
Detection of various forms of brain myelin basic protein in vertebrates by electroimmunoblotting. Neurochem Res (1984) 1.00
T-cell dependence of immune response to hepatitis B antigen in mice. Nature (1975) 0.99
Perivascular T cells express the pro-inflammatory chemokine RANTES mRNA in multiple sclerosis lesions. Scand J Immunol (1997) 0.98
Binding of complement component Clq to myelin oligodendrocyte glycoprotein: a novel mechanism for regulating CNS inflammation. Mol Immunol (1997) 0.97
Susceptibility and resistance to experimental autoimmune encephalomyelitis and neuritis in the guinea pig correlate with the induction of procoagulant and anticoagulant activities. J Immunol (1984) 0.97
Antibodies to type II collagen and HLA disease susceptibility markers in rheumatoid arthritis. Arthritis Rheum (1999) 0.95
Gamma delta T cell receptor repertoire in brain lesions of patients with multiple sclerosis. J Neuroimmunol (1993) 0.93
IgG subclass switching is associated with the severity of experimental autoimmune encephalomyelitis induced with myelin oligodendrocyte glycoprotein peptide in NOD mice. Cell Immunol (1999) 0.92
Macrophage procoagulant activity as a measure of cell-mediated immunity to P2 protein of peripheral nerves in the Guillain-Barré syndrome. J Neuroimmunol (1985) 0.91
Experimental autoimmune orchitis in T-cell-deficient mice. Int Arch Allergy Appl Immunol (1978) 0.91
Ontogeny of immunity in amphibians: changes in antibody repertoires and appearance of adult major histocompatibility antigens in Xenopus. Eur J Immunol (1979) 0.90
Concomitant detection of changes in myelin basic protein and permeability of blood-spinal cord barrier in acute experimental autoimmune encephalomyelitis by electroimmunoblotting. J Neuroimmunol (1985) 0.90
Axonal degeneration is an early pathological feature in autoimmune-mediated demyelination in mice. Microsc Res Tech (2001) 0.90
Antibody response in Lewis rats injected with myelin oligodendrocyte glycoprotein derived peptides. Int Immunol (1996) 0.90
Inhibition by serum of encephalitogenic activity of myelin basic protein: nature of the serum factor responsible. Cell Immunol (1975) 0.89
Experimental autoimmune encephalomyelitis. An anatomically-based explanation of clinical progression in rodents. J Neuroimmunol (1982) 0.89
Regulation of myelin oligodendrocyte glycoprotein in different species throughout development. Dev Neurosci (1997) 0.88
Active suppression of the allogeneic histocompatibility reactions during the metamorphosis of the clawed toad Xenopus. Differentiation (1980) 0.87
Genetic control of T helper cell function in the clawed toad Xenopus laevis. Eur J Immunol (1981) 0.86
In vitro evidence for T-B lymphocyte collaboration in the clawed toad, Xenopus. Eur J Immunol (1980) 0.86
Characterization of cDNA and genomic clones encoding human myelin oligodendrocyte glycoprotein. J Neurochem (1995) 0.86
Association of susceptibility to multiple sclerosis with TCR genes. Immunol Today (1992) 0.85
Changes of extracellular space volume and tortuosity in the spinal cord of Lewis rats with experimental autoimmune encephalomyelitis. Physiol Res (1996) 0.84
The epigenetics of multiple sclerosis: clues to etiology and a rationale for immune therapy. Annu Rev Neurosci (1994) 0.84
Expression, purification, and encephalitogenicity of recombinant human myelin oligodendrocyte glycoprotein. J Neurochem (1998) 0.84
A conformational study of the human and rat encephalitogenic myelin oligodendrocyte glycoprotein peptides 35-55. Eur J Biochem (1997) 0.84
Use of protein-bearing nitrocellulose as immunogen for in vitro production of monoclonal antibodies: application to myelin basic protein electrophoretically separated from a complex brain protein mixture. Immunol Lett (1987) 0.83
Differing epitope selection of experimentally-induced and natural antibodies to a disease-specific autoantigen, the E2 subunit of pyruvate dehydrogenase complex (PDC-E2). Int Immunol (1992) 0.82
Demyelinating antibodies to myelin oligodendrocyte glycoprotein and galactocerebroside induce degradation of myelin basic protein in isolated human myelin. J Neurochem (1997) 0.82
Transfer of murine experimental autoimmune encephalomyelitis and cell-mediated immunity to myelin protein is effected by Lyt-1 cells. J Neuroimmunol (1983) 0.82
Antibody to myelin basic protein in extracts of multiple sclerosis brain. Immunology (1981) 0.82
Solubilization and characterization of moderate and high affinity histamine binding sites on human blood mononuclear cells. Mol Immunol (1987) 0.81
Electroimmunoblotting of small peptides separated on urea-dodecyl sulphate (SUDS) gels. Application to myelin basic protein. J Immunol Methods (1988) 0.81
Do antibodies to myelin basic protein isolated from multiple sclerosis cross-react with measles and other common virus antigens? Clin Exp Immunol (1983) 0.81
The development of autoimmune encephalomyelitis provoked by myelin oligodendrocyte glycoprotein is associated with an upregulation of both proinflammatory and immunoregulatory cytokines in the central nervous system. J Interferon Cytokine Res (1998) 0.81
Gm allotypes and multiple sclerosis. J Immunogenet (1982) 0.81
Quantitative electroimmunoblotting study of the calcium-activated neutral protease in human myelin. J Neurochem (1986) 0.80
Inhibition by serum of encephalitogenic activity of myelin basic protein. Int Arch Allergy Appl Immunol (1975) 0.80
Durability of immune protection against experimental autoimmune encephalomyelitis. Cell Immunol (1976) 0.80
Purified antichick Thy-1 IgG abolishes intermediate and long-term memory. Physiol Behav (1993) 0.79
Preparation of highly purified human myelin oligodendrocyte glycoprotein in quantities sufficient for encephalitogenicity and immunogenicity studies. Biochem Mol Biol Int (1993) 0.79
HTLV-I sequences are not detected in peripheral blood genomic DNA or in brain cDNA of multiple sclerosis patients. Ann Neurol (1990) 0.79
Improved detection of lymphocyte membrane proteins in purified form and as a crude mixture using native and denaturing polyacrylamide gel electrophoresis by optimisation of coomassie brilliant blue and silver staining. Electrophoresis (1990) 0.79
Comparison of the rat and mouse encephalitogenic determinants. Adv Exp Med Biol (1978) 0.78
Cell-mediated immune response to copolymer I in multiple sclerosis measured by the macrophage procoagulant activity assay. Int Immunol (1990) 0.78
Multiple sclerosis brain immunoglobulins stimulate myelin basic protein degradation in human myelin: a new cause of demyelination. J Neurochem (1989) 0.78
Bcl-2 transgenic mice with increased number of neurons have a greater learning capacity. Brain Res (1999) 0.78
Intrathecal administration of neutralizing antibody against Fas ligand suppresses the progression of experimental autoimmune encephalomyelitis. Biochem Biophys Res Commun (2000) 0.77
Human myelin/oligodendrocyte glycoprotein: a new member of the L2/HNK-1 family. J Neurochem (1993) 0.77
The effect of HLA-DRB1 disease susceptibility markers on the expression of RA. Scand J Rheumatol (1997) 0.77
Immunosusceptibility genes in rheumatoid arthritis. Hum Immunol (1996) 0.77
Influence of HLA-DR2, HLA-DPw4, and T cell receptor alpha chain genes on the susceptibility to multiple sclerosis. Int Immunol (1992) 0.77
Delayed and incomplete myelination in a transgenic mouse mutant with abnormal oligodendrocytes. J Neurosci Res (1997) 0.77
Inhibition of memory in the chick using a monoclonal anti-Thy-1 antibody. J Neuroimmunol (1987) 0.76
Human myelin/oligodendrocyte glycoprotein: a new member of the L2/HNK-1 family. Schweiz Arch Neurol Psychiatr (1993) 0.76
Epidermal growth factor inhibits the expression of myelin basic protein in oligodendrocytes. J Neurosci Res (1989) 0.76
Copper salicylate as an anti-inflammatory and analgesic agent in arthritic rats. Life Sci (1983) 0.76
Fas has a crucial role in the progression of experimental autoimmune encephalomyelitis. Mol Immunol (1998) 0.76
DNA vaccines for the treatment of autoimmune disease. Immunol Cell Biol (1997) 0.75
Molecular detection of interferon-alpha expression in multiple sclerosis brain. J Neuroimmunol (1993) 0.75
Survival and tissue localization of xenogeneic human lymphocytes in hypothymic nude mice: observations in normal subjects and multiple sclerosis. Clin Exp Immunol (1984) 0.75
Incomplete Freund's adjuvant enhances locomotor performance following spinal cord injury. Eur J Neurol (2005) 0.75
Developmental study of myelin basic protein variants in various regions of pig nervous system. J Neurochem (1989) 0.75
Flow microfluorometry detects IgM autoantibody to oligodendrocytes in multiple sclerosis. J Neuroimmunol (1983) 0.75
Solid phase radioimmunoassay for human myelin basic protein using a monoclonal antibody. J Neuroimmunol (1983) 0.75
Criteria for an adequate explanation of typical clinical signs of EAE in rodents. Prog Clin Biol Res (1984) 0.75
A nondenaturing vertical isoelectric focusing polyacrylamide slab gel system suitable for silver staining and electrophoretic blotting. Anal Biochem (1988) 0.75
Experimental autoimmune encephalomyelitis in mice: Lyt and Ia phenotypes of the effector and suppressor cells. Prog Clin Biol Res (1984) 0.75
Evolutionary divergence in the structure of myelin basic protein: comparison of chondrichthye basic proteins with those from higher vertebrates. J Neurochem (1986) 0.75
Correlation of the onset of experimental autoimmune encephalomyelitis-like clinical signs with oedema of the spinal cord in tunicamycin-poisoned rats. J Neurol Sci (1987) 0.75
Electroimmunoblotting of myelin basic protein peptides: a novel approach to the rapid characterisation of antigenic specificities of monoclonal and polyclonal anti-MBP antibodies. J Neuroimmunol (1988) 0.75
Rapid characterization of protein epitopes recognized by monoclonal antibodies using direct probing on thin-layer and paper chromatograms. J Immunol Methods (1987) 0.75
Inhibition of long-term memory formation in the chicken by anti chick Thy-1 antibody. Brain Res Bull (1983) 0.75
Absence of cross-reactive antibodies to myelin and viral antigens in multiple sclerosis. Prog Clin Biol Res (1984) 0.75
Solubilization and characterization of a low-affinity histamine-binding site on human blood mononuclear cells. Mol Immunol (1986) 0.75
Molecular detection and quantitation of the chemokine RANTES mRNA in neurological brain. APMIS (1998) 0.75